Abstract: High throughput screening of SICLOPPS libraries afforded six distinct cyclic peptides that inhibit Escherichia coli growth both in liquid and solid media. One of these peptides (LN05) reduced both bacterial growth rate and caused cell aggregation in liquid media. Mutant bacteria immune to LN05 action were obtained at a frequency of 10 -7 . Over-expression of an E. coli genomic library in the presence of LN05 production resulted in enrichment of a single genomic construct, a fragment of the NarZ gene.
INTRODUCTION
Antimicrobial resistance has proven a formidable scourge that causes more than eleven million people to die every year from preventable or curable diseases [1] . The general response to the spread of antimicrobial resistance has been to modify existing drugs to create generation after generation of antibiotics that inhibit the same cellular targets. As a result, infective microbes have been able to stay one step ahead of medical treatments by neutralizing new drugs with the old resistance mechanisms. This situation has created a paradox where increased antimicrobial resistance is met with fewer new drugs, meanwhile the genomic information of numerous infectious agents remain unexploited for essential metabolic activities [2] .
Currently, 170 microbial genomes have been solved. One striking result, repeated across different species, is that 30-50% of all detected ORFs have unknown metabolic functions. The large influx of new gene sequences has left the formidable task of elucidating the biological role of the encoded proteins. In the field of antibiotic research two additional hurdles need to be overcome: First is determining which genes are essential for cell viability; second is the requirement to distill into a single molecular structure, the functional and chemical determinants necessary to make new antibiotics.
To our knowledge, no available method simultaneously identifies new antimicrobial compounds while interrogating complete genomes to detect the affected biological functions. Such a method would require the ability to screen large collections of small molecules for their capacity to change cellular phenotypes.
The natural choice to explore molecular diversity at the cellular level are small, genetically encoded peptides. However, the use of peptides as intracellular probes has been hampered by their instability against cellular catabolism. Cyclization affords a way to stabilize peptides against proteolysis, thus allowing their application in the search for inhibitors of intracellular targets. We have recently [3] demonstrated the feasibility of utilizing the ligase activity of inteins for the in vivo backbone cyclization of peptidic chains. This procedure -called SICLOPPS for Split Intein Circular Ligation Of Peptides and ProteinS-has been applied in the creation of large collections of nine and six amino acid cyclic peptides [4] . Libraries of SICLOPPS peptides allow the co-localization of small molecule probes and their targets in a biologically relevant environment, which simplifies the search for new antimicrobial targets while simultaneously providing drug-like compounds to inhibit the detected enzymatic function [5] .
In this report we tested SICLOPPS libraries for cyclic peptides that inhibit normal E. coli growth.
Furthermore, we used functional complementation to detect potential intracellular targets of one of the bacteriostatic peptides found.
MATERIALS AND METHODS

a. Reagents, plasmids and bacterial strains: Enzymes for molecular biology were obtained from Invitrogen Life
Technologies, (Carlsbad, CA), Promega Corporation (Madison, WI), and New England Biolabs (Beverly, MA).
All other chemicals were of analytical grade or better. E. coli strain DH5α-PRO and plasmid pPROTet.E133
were from Clontech (Palo Alto, CA). E. coli strain TUNER(DE3) and plasmid pET24d were from Novagen (Madison, WI). E. coli strain XL1-Blue was from Stratagene (La Jolla, CA). Plasmid pMAL-C2X was from New England Biolabs. Plasmid pBAD/HisB was from Invitrogen. The pDIMC7 plasmid was a generous gift from Prof. Stephen Benkovic, the Pennsylvania State University, PA.
b. Construction of genomic library expression vector: pPROTet.E133 (10 ng/µl) was digested with BamHI (0.5 u/µl) for 4.5 h at 37 °C. The digested plasmid was subsequently dephosphorylated by adding 1 µl shrimp alkaline phosphatase directly to the digestion mixture, and further incubated for 1h at 37 °C. Genomic DNA was prepared from E. coli XL1-Blue. The genomic DNA was digested with Sau3AI to give DNA fragments ranging from 500 bp to 3000 bp.
The digested vector and genomic DNA fragments were ligated following standard procedures [6] to yield pPRO(Ecoli_genomic). After ligation, the mixture was digested with BamHI, prior to transformation into electro competent E. coli DH5α-PRO. The transformed population yielded approximately 1.5*10 5 colonies.
Plasmid DNA was extracted from individual colonies and analyzed by digestion with NcoI. The majority of inserts were between 900 and 1200 bp long. Approximately 20% of the plasmids tested were parental pPROTet.E133. Transformed colonies were pooled and stored as a 20 % glycerol stock at -80 °C.
c. Construction of SICLOPPS libraries:
The I C fragment of the DnaE split intein from Synechocystis sp.
PCC6803 was cloned between the SacI and EcoRI sites of pMAL-C2X. The I N fragment was cloned downstream of I C using the XbaI and HindIII sites to yield pMAL(SICLOPPS). Two different SICLOPPS libraries were prepared following published procedures [7] . Both peptide libraries have four fixed positions (serine, glycine, proline, and leucine) to improve cyclization efficiency. Aliquots containing 10 3 CFU were individually plated on non-inducing LB agar to determine the actual CFU.
All plates were incubated overnight at 37 o C. Survival percentage for each sample was obtained by dividing the CFU of induced cultures by the CFU of non-induced cultures.
f. Appearance of cell strains resistant to SICLOPPS peptides: DH5αPRO cells transformed with pMAL(LN05)
were diluted with LB media and 10 9 CFU were plated on inducing LB agar as above. After 48 hours incubation at 37 o C, plates were scored for normal size colonies (as compared with noninducing plates) above a background of pin-point colonies. Four normal sized and one pin-point colonies were picked and grown in LB media overnight at 37 o C. The resulting cell cultures were diluted to OD 600 < 0.1. Cells were incubated at 37 °C until OD 600 = 0.4. Every cell culture was divided into two aliquots. One aliquot was treated with IPTG to a final concentration of 1 mM and the other was treated with equal volume of distilled water. All fractions were further incubated overnight at 37 °C. A 500 µl aliquot from each culture was concentrated by centrifugation. Cell pellets were diluted with SDS-PAGE loading buffer to a final OD 600 = 20.0. Cell suspensions were incubated in boiling water for 15 minutes and 5 µl loaded on a 15% SDS-PAGE gel. The gel was run with Tris-glycine buffer for 30 minutes and stained with Coomassie brilliant blue.
g. Selection of genomic fragments that counteract peptide action: DH5αPRO cells containing pPRO(Ecoli_genomic) were transformed with either pMAL(LN05) or pMAL(SICLOPPS) (Fig. 2, a were incubated overnight at 37 °C. Cells overexpressing the inhibited gene product will produce an excess of the targeted activity, thus overcoming peptide inhibition and rescuing growth (Fig. 2, b & c) . DNA from ten individual colonies from the IPTG / aTc plate was isolated and genomic constructs identities determined by DNA sequencing. All colonies from the IPTG / aTc plate were pooled and the plasmid DNA extracted. The resulting plasmid mixture was retransformed in DH5αPRO cells (Fig. 2, d ). The selection scheme was repeated to remove false positives resulting from naturally appearing resistance not associated with genomic construct over-expression. Since SICLOPPS precursor protein is soluble when expressed at 28 o C, but form inclusion bodies at 37 o C, temperature-dependent induction provides for a sensitive test on the toxic effect of soluble SICLOPPS intermediates [4] . Peptide production at 28 o C caused complete growth inhibition by selected pBAD(∆4+5) constructs, while expression of the same constructs at 37 o C had only a slight effect on growth rate.
Expressing the pET(∆4+5) or pET(∆4+6) libraries from a moderately strong T7 promoter ameliorated toxicity, although 30-50 % of the cells lost the ability to produce the precursor protein altogether. This result is probably due to the loss of the integrated DE3 prophage needed for induction from T7-based expression vectors -a typical response to toxic product expression in cells containing an integrated prophage-. The T7 promoter was also induced with lactose to test if toxicity could arise from sugar metabolism. No difference in bacterial growth rate was seen when peptide production was induced with lactose or its non-hydrolysable analog, IPTG.
Both pMAL(∆4+6) and pDIMC(∆4+6) were expressed from a weak Tac promoter. However, pMAL(∆4+6) has a ColE1 origin of replication which allows maintenance of 75-100 plasmid copies per cell.
On the other hand, pDIMC(∆4+6) has a p15A origin of replication that only sustains 15 plasmid copies per cell. The six peptides identified have an amphiphilic character but share no obvious sequence homology ( Table 1 ). All of them, however, were able to stop cell growth upon induction. Furthermore, cells expressing these constructs showed no propidium iodide uptake (data not shown).
Thus, these peptides did not target cellular membranes and may stop cell growth by inhibiting different essential enzymatic pathways. One of these constructs, LN05, not only inhibited cell growth, but caused extensive bacterial aggregation when grown in liquid media. Similar phenotypes have been seen when cell structural proteins have been deleted from the bacterial genome [8] . Thus, we expect that the LN05 peptide is inhibiting the function of proteins necessary to maintain cell integrity or other membrane-bound proteins. showed different genomic constructs in each one. However, two of the constructs sequenced corresponded to fragments of the NarZ and NarG genes. These two genes encode for the same physiological function, namely, both take part in the reduction of nitrates to nitrites. Ten constructs sequenced from pMAL(SICLOPPS)/pPRO(Ecoli_genomic) transformed cells showed totally different genomic sequences. All colonies from the pMAL(LN05)/pPRO(Ecoli_genomic) plate were harvested, DNA was extracted and used to transform fresh DΗ5α-PRO cells. The resulting transformed cells were selected as above. DNA from ten colonies was sequenced. Three clones corresponded to the NarZ gene previously detected. Under these conditions, the probability of randomly picking out the same genomic construct three times out of ten is 10 -6 .
Cells expressing LN05 peptide alone, LN05 peptide together with the empty pPROTet.E133 vector, and LN05 peptide together with the NarZ fragment were individually plated onto LB agar supplemented with 0.1 µg/ml aTc and either 0 or 1 mM IPTG. As before, LN05 peptide production prevented colony formation when expressed alone ( shown). However, when the NarZ fragment was co-expressed with the LN05 peptide, CFU number and colony growth rate was similar for the IPTG induced and non-induced plates (Fig. 5, bottom panels) . Co-expression of genomic constructs other than NarZ or NarG failed to rescue cell viability (data not shown).
There are three nitrate reductases in E. coli, one periplasmic, Nap (encoded by the napFDAGHBC operon), and two membrane bound, Nitrate Reductase A (NRA, encoded by the narGHJI operon) and Nitrate
Reductase Z (NRZ, encoded by the narZYWV operon). Double and triple knockout mutants has been made where either both membrane-bound or all three nitrate reductases were compromised. These knockout clones grow under aerobic, suggesting that nitrate reductases are not essential under aerobic conditions [9] . Since two apparently redundant nitrate reductase enzymes are maintained, the membrane bound reductases may have different physiological functions. These nitrate reductases seem to have evolved by gene duplication because the transcription unit is homologous with 73% identity [10] . Interestingly, they are regulated very differently:
NRA is regulated by oxygen and nitrate levels and therefore expressed only during anaerobic conditions. NRZ is constitutively expressed at low levels during exponential growth, and induced by RpoS during stationary phase under aerobic conditions [11] . The fact that NarZ is not essential under aerobic conditions is consistent with our results. The LN05 peptide slows down bacterial growth rate, but does not cause bacterial death. Furthermore, immediately after plating, cells will be in the exponential phase where expression of the NRZ operon is at its lowest levels. If the LN05 peptide inhibits NarZ, cell growth would be slowed (as seen in our results). Thus, no colony formation would be detected. Over time, plated cells would enter into stationery phase with concomitant increased expression of NRZ operon. The increased NarZ concentration, would reduce the inhibitory effect of LN05, allowing the formation of visible colonies. This is, again, consistent with our observations that pin-point colony formation can be seen at very high plate density (where there is strong competition for available IPTG) or after long incubation times (where most cells will have entered into stationary growth phase).
SUMMARY
We have developed a novel genetic method to interrogate complete genomes for gene product function.
Using plate replication as a selection tool, we identified six different peptides that stop bacterial growth. One of these peptides (LN05) also caused bacterial aggregation upon expression. Functional complementation detected a NarZ gene fragment that counteracted LN05 peptide action. Further characterizations of NarZ-LN05 interaction, as well as identification of metabolic functions inhibited by the other peptides are under way.
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